Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology Annual Meeting Life Science Investing
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET Life Science Investing
New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer's Disease Life Science Investing
Republic Technologies Closes First Tranche of the Non-Brokered Private Placement of Special Warrants Medical Device Investing
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights Biotech Investing
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update Life Science Investing
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update Life Science Investing
BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
